The Effect of Finasteride in Men with Benign Prostatic Hyperplasia
- 22 October 1992
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 327 (17) , 1185-1191
- https://doi.org/10.1056/nejm199210223271701
Abstract
Benign prostatic hyperplasia is a progressive, androgen-dependent disease resulting in enlargement of the prostate gland and urinary obstruction. Preventing the conversion of testosterone to its tissue-active form, dihydrotestosterone, by inhibiting the enzyme 5α-reductase could decrease the action of androgens in their target tissues; in the prostate the result might be a decrease in prostatic hyperplasia and therefore in symptoms of urinary obstruction.Keywords
This publication has 13 references indexed in Scilit:
- The Clinical Effects of a 5α-Reductase Inhibitor, Finasteride, on Benign Prostatic HyperplasiaJournal of Urology, 1992
- The clinical development of a 5α-reductase inhibitor, finasterideThe Journal of Steroid Biochemistry and Molecular Biology, 1990
- Effects of Finasteride (MK-906), a 5α-Reductase Inhibitor, on Circulating Androgens in Male Volunteers*Journal of Clinical Endocrinology & Metabolism, 1990
- Serum prostate-antigen levels in patients with benign prosttic hypertrophy treated with leuprolideUrology, 1989
- Effect of MK‐906, a Specific 5α‐reductase Inhibitor, on Serum Androgens and Androgen Conjugates in Normal MenJournal of Andrology, 1989
- Mortality and Reoperation after Open and Transurethral Resection of the Prostate for Benign Prostatic HyperplasiaNew England Journal of Medicine, 1989
- Treatment of Benign Prostatic Hyperplasia by Androgen Deprivation: Effects on Prostate Size and Urodynamic ParametersJournal of Urology, 1989
- The Effect of Nafarelin Acetate, a Luteinizing-Hormone–Releasing Hormone Agonist, on Benign Prostatic HyperplasiaNew England Journal of Medicine, 1987
- Steroid 5α-Reductase Deficiency in Man: An Inherited Form of Male PseudohermaphroditismScience, 1974
- Familial Incomplete Male Pseudohermaphroditism, Type 2New England Journal of Medicine, 1974